SHANDONG XINHUA PHARMACEUTICAL CO revenue breakdown overview

SHANDONG XINHUA PHARMACEUTICAL CO revenue for the last year amounted to 9.01 B HKD, the most of which — 4.42 B HKD — came from its highest performing source at the moment, Preparation, the year earlier bringing 4.02 B HKD. The greatest contribution to the revenue figure was made by China (including Hong Kong) — last year it brought SHANDONG XINHUA PHARMACEUTICAL CO 6.87 B HKD, and the year before that — 6.56 B HKD.